Search:
Search Results (Query (Product Name) = *Valsartan*):
| Product Name | Country | Manufacture | Chemical formula | CAS # | CEP | DMF |
| Valsartan | India | Ranbaxy Laboratories Ltd |
C24H29N5O3 | 137862-53-4 | US EC - | |
| Valsartan | China | ZHEJIANG HUAHAI PHARMACEUTICAL CO.LTD. |
C24H29N5O3 | 137862-53-4 | US EC - | |
| Valsartan | India | Alembic Limited |
C24H29N5O3 | 137862-53-4 | R0-CEP 2010-065-Rev 00 | - - - |
| Valsartan | India | DR REDDYS LABORATORIES LTD |
C24H29N5O3 | 137862-53-4 | R0-CEP 2009-405-Rev 00 | - - - |
| Valsartan | Israel | TEVA GROUP | C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | Matrix Laboratories Ltd |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | JUBILANT LIFE SCIENCES LIMITED |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | Lupin Ltd |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | DR REDDYS LABORATORIES LTD |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP | India | Alembic Limited |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | Aurobindo Pharma Ltd. |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | Cadila Pharmaceuticals Ltd. |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP | India | IPCA Laboratories Ltd |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP | India | Cadila Pharmaceuticals Ltd. |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP | Mexico | APOTEX PHARMACHEM INC |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP (PROCESS II) | China | ZHEJIANG HUAHAI PHARMACEUTICAL CO.LTD. |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP (PROCESS II) | India | Alembic Limited |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | Ireland | NOVARTIS PHARMACEUTICALS CORP | C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP | India | MACLEODS PHARMACEUTICALS LIMITED |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP (PROCESS II) | India | Aurobindo Pharma Ltd. |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | Teva Group |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan USP | India | Divis Laboratories Ltd. |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | India | Hetero Drugs Ltd |
C24H29N5O3 | 137862-53-4 | US - - | |
| Valsartan | China | Second Pharma Co.Ltd. |
C24H29N5O3 | 137862-53-4 | US - - | |
| VALSARTAN | India | SHREEJI PHARMA INTERNATIONAL |
137862-53-4 | - - - | ||
| Valsartan | India | SHREEJI PHARMA INTERNATIONAL |
137862-53-4 | - - - | ||
| Valsartan USP | India | SHREEJI PHARMA INTERNATIONAL |
137862-53-4 | - - - | ||
| Valsartan USP | United States | Tecoland Corp. |
C24H29N5O3 | 137862-53-4 | US EC - | |
| Valsartan USP, EP (Technical Pack) | United States | Tecoland Corp. |
C24H29N5O3 | 137862-53-4 | - - - |